[1]
Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin., 2016, 66(1), 7-30.
[2]
Doll, R.; Peto, R.; Boreham, J.; Sutherland, I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ, 2004, 328(7455), 1519.
[3]
Malhotra, J.; Malvezzi, M.; Negri, E.; La Vecchia, C.; Boffetta, P. Risk factors for lung cancer worldwide. Eur. Respir. J., 2016, 48(3), 889-902.
[4]
Christakos, S.; Dhawan, P.; Verstuyf, A.; Verlinden, L.; Carmeliet, G.; Vitamin, D. Metabolism, molecular mechanism of action, and pleiotropic effects. Physiol. Rev., 2016, 96(1), 365-408.
[5]
Bandera Merchan, B.; Morcillo, S.; Martin-Nuñez, G.; Tinahones, F.J.; Macías-González, M. The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences. J. Steroid Biochem. Mol. Biol., 2017, 167, 203-218.
[6]
Vaughan-Shaw, P.G.; O’Sullivan, F.; Farrington, S.M.; Theodoratou, E.; Campbell, H.; Dunlop, M.G.; Zgaga, L. The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: Systematic review and meta-analysis. Br. J. Cancer, 2017, 116(8), 1092-1110.
[7]
Zella, L.A.; Kim, S.; Shevde, N.K.; Pike, J.W. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol. Endocrinol., 2006, 20(6), 1231-1247.
[8]
Santagata, S.; Thakkar, A.; Ergonul, A.; Wang, B.; Woo, T.; Hu, R.; Harrell, J.C.; McNamara, G.; Schwede, M.; Culhane, A.C.; Kindelberger, D.; Rodig, S.; Richardson, A.; Schnitt, S.J.; Tamimi, R.M.; Ince, T.A. Taxonomy of breast cancer based on normal cell phenotype predicts outcome. J. Clin. Invest., 2014, 124(2), 859-870.
[9]
Berlanga-Taylor, A.J.; Knight, J.C. An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin D. Mol. Diagn. Ther., 2014, 18(3), 261-272.
[10]
Bi, X.B. Vitamin D receptor gene polymorphism and genetic susceptibility of nonsmall cell lung cancer. J. Trop. Med., 2016, 16(7), 905-908.
[11]
Dogan, I.; Onen, H.I.; Yurdakul, A.S.; Konac, E.; Ozturk, C.; Varol, A.; Ekmekci, A. Polymorphisms in the vitamin D receptor gene and risk of lung cancer. Med. Sci. Monit., 2009, 15(8), BR232-BR242.
[12]
Kaabachi, W.; Kaabachi, S.; Rafrafi, A.; Amor, A.B.; Tizaoui, K.; Haj Sassi, F.; Hamzaoui, K. Association of vitamin D receptor FokI and ApaI polymorphisms with lung cancer risk in Tunisian population. Mol. Biol. Rep., 2014, 41(10), 6545-6553.
[13]
Li, R. Relationship between vitamin D receptor gene rs7975232 single nucleotide polymorphism and lung cancer risk. Chinas. Med., 2013, 8(10), 1390-1392.
[14]
Wei, M.D.; Su, G-S.; Ling, Z.G.; Wei, S.Q.; Guangxi, L. Clinical study effection of vitamin D receptor gene polymorphism on the susceptibility of lung squamous cell carcinoma, and chemotherapy curative. Chronic Pathematol. J., 2014, 15(5), 349-351.
[15]
Wu, X.; Cheng, J.; Yang, K. Vitamin D-related gene polymorphisms, plasma 25-hydroxy-vitamin d, cigarette smoke and non-small cell lung cancer (NSCLC) risk. Int. J. Mol. Sci., 2016, 17(10), E1597.
[16]
Yang, H.; Zhou, W.; Tang, J.; Qi, Z.M.; Hou, Y.Y.; Cai, L.; Pan, F.D.; Peng, Y. The interactive influence of Vitamin D receptor genetic polymorphism and smoking on non-small-cell lung cancer. Chinese J. Gerontol., 2013, 33(16), 3844-3846.
[17]
Fu, Y.; Li, J.; Zhang, Y. Polymorphisms in the vitamin D receptor gene and the lung cancer risk. Tumour Biol., 2014, 35(2), 1323-1330.
[18]
Zhong, H.; Zhou, R.; Feng, Y.; Zheng, G.X.; Liang, Y.; Zhang, J.Y.; Qin, X.Q.; Chen, W.; Wu, J.Q.; Zhong, Y.H. Association of vitamin D receptor gene polymorphism with the risk of lung cancer: A meta-analysis. J. Recept. Signal Transduct. Res., 2014, 34(6), 500-505.
[19]
Xu, J.; Turner, A.; Little, J.; Bleecker, E.R.; Meyers, D.A. Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: Hint for genotyping error? Hum. Genet., 2002, 111(6), 573-574.
[20]
Cai, L.N.; Yang, Y.H.; Qi, Z.M.; Fu, Z.Z.; Tang, L.J.; Yu, Z.Y. The relationship between vitamin D receptor gene BmsI sites polymorphisms and hereditary susceptibility to non-small-cell lung cancer. Chin. J. Coal Ind. Med., 2012, 15(3), 321-324.
[21]
Tang, L.J.; Yang, Y.H.; Cai, L.; Yu, Z.G. QiI, Z.M.; Fu, Z.Z. Association of vitamin D receptor BsmI and TaqI polymorphisms with non-small-cell lung cancer risk. Shandong Med. J., 2012, 52(43), 40-41.
[22]
Gandini, S.; Gnagnarella, P.; Serrano, D.; Pasquali, E.; Raimondi, S. Vitamin D receptor polymorphisms and cancer. Adv. Exp. Med. Biol., 2014, 810, 69-105.
[23]
Xiong, L.; Cheng, J.; Gao, J.; Wang, J.; Liu, X.; Wang, L. Vitamin D receptor genetic variants are associated with chemotherapy response and prognosis in patients with advanced non-small-cell lung cancer. Clin. Lung Cancer, 2013, 14(4), 433-439.
[24]
Heist, R.S.; Zhou, W.; Wang, Z.; Liu, G.; Neuberg, D.; Su, L.; Asomaning, K.; Hollis, B.W.; Lynch, T.J.; Wain, J.C.; Giovannucci, E.; Christiani, D.C. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J. Clin. Oncol., 2008, 26(34), 5596-5602.
[25]
Kilkkinen, A.; Knekt, P.; Heliövaara, M.; Rissanen, H.; Marniemi, J.; Hakulinen, T.; Aromaa, A. Vitamin D status and the risk of lung cancer: A cohort study in Finland. Cancer Epidemiol. Biomarkers Prev., 2008, 17(11), 3274-3278.
[26]
Zhou, W.; Heist, R.S.; Liu, G.; Asomaning, K.; Neuberg, D.S.; Hollis, B.W.; Wain, J.C.; Lynch, T.J.; Giovannucci, E.; Su, L.; Christiani, D.C. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J. Clin. Oncol., 2007, 25(5), 479-485.
[27]
Van Renterghem, D. Lung cancer survival: vitamin D could be just a marker of physical fitness. J. Clin. Oncol, 2007. 25(34), 5537-5538;
(author reply 5538-5539).